[12] Silena Barton-Wechsler, David L Stachura, Emily Ho, et al
Identifying similarities between metabolite alterations in GWS and ME/CFS is an important step toward uncovering potential therapeutic targets and enhancing our understanding of the underlying pathophysiology that contributes to shared symptoms, such as fatigue
Therefore, DPP4i is particularly suitable for use in elderly, frail and/or vulnerable patients whose long-term type 2 diabetes and its complications often result in multidrug therapy
The recent addition of an oral Wegovy option allows patients to choose between injections and pills, accommodating personal preferences
Supplements such as BCAA (512 g/day), leucine (6 g/day), -Hydroxy--methylbutyrate (3 g/day), creatine (20 g/day for 57 days, followed by maintenance dose of 35 g/day), omega-3 fatty acids (24 g/day) and vitamin D (8001000 IU/day) may offer additional benefits in improving the health and quality of life of patients with sarcopenia, especially when balanced hypocaloric diet with adequate protein intake and physical exercise are insufficient to maintain muscle mass and function [50]
How does PlexusDx genetic testing help me choose between medications
